Recently, Novo Nordisk announced the launch of Novo Nordisk's Simaglutide Injection for long-term weight management in China. How is the sales situation on e-commerce channels? On November 22nd, when the reporter opened e-commerce platforms such as Meituan and JD.com to buy medicine, it was found that online appointments and in store outpatient services for Novo Nordisk could already be searched.
On the Meituan platform, the current selling price of 1.5 milliliters (0.68 milligrams/milliliter) of Nuoheying is 1630 yuan. It is understood that this price will fluctuate up and down, including registration, diagnosis, treatment, medication pickup, and appointment services. The person in charge of Meituan Pharmaceutical revealed that the Nuoheying appointment service was launched on November 9th, and the keyword search popularity of Nuoheying increased by more than 6 times compared to the previous month; Since Novo Nordisk announced its listing on November 17th, its search volume has skyrocketed 22 times.
The supply on the platform is mainly provided by private clinics, such as Aikang, Yufang, Health Network, and other institutions. "The person in charge of Meituan Maiyao said that currently, users in 27 cities including Beijing, Shanghai, Guangzhou, Shenzhen, and Hangzhou can experience the full process solution of" in store consultation - evaluation and prescription - medication collection - medication guidance - weight loss management files ", and users in other regions can also choose other convenient medication collection methods.
It is understood that Nuohe Ying has strict restrictions on its user population, mainly used for adult weight loss, requiring users to have an initial BMI (body mass index) of over 30 or between 27 and 30, and at least one weight related complication, such as abnormal blood sugar, blood pressure, blood lipids, etc. Patients who meet the indications can receive medication once a week.
Professor Ji Linong, Director of the Endocrinology Department at Peking University People's Hospital, said, "Patients with clinical weight loss needs should go to regular medical institutions for evaluation and diagnosis, and receive scientific weight loss treatment. When lifestyle management cannot achieve weight loss goals, medical weight loss treatment can be combined on this basis; GLP-1RA drugs, represented by, provide an important clinical option for doctors and patients to jointly develop weight loss strategies. The application of such prescription drugs requires strict adherence to indications. Patients should strictly follow the prescribed medication guidelines to ensure the effectiveness and safety of their medication